Visceral leishmaniasis and its link to lymphocytic clone expansion. A case ‑ reporte and a literatura review
ISSN 2250-8309 (versión en línea) - ISSN 0329-0379 (versión impresa)
pdf (Español (España))

Keywords

visceral leishmaniasis, clonality, immune deregulation

How to Cite

Marull, M. del C., Fernández, C., Stemberg, E., & Bernard, H. (2019). Visceral leishmaniasis and its link to lymphocytic clone expansion. A case ‑ reporte and a literatura review. Journal of Hematology, 22(1), 75–80. Retrieved from https://mail.revistahematologia.com.ar/index.php/Revista/article/view/114

Abstract

We present the case of a 19-year-old male patient without prior medical conditions who referred a five-day history of asthenia, anorexia, weight loss, epistaxis and fever. Hepatosplenomegaly and pancytopenia were observed at clinical examination. A bone marrow aspiration was performed to rule out a lymphoproliferative syndrome versus systemic parasitosis: it showed the presence of macrophages with corpuscular parasitic elements that were suspicious of Leishmaniasis spp. In flow cytometry examination the presence of a monoclonal lymphocytes B expansion was observed. Discussion. Leishmaniasis stands for a group of diseases caused by a protozoon of the Leishmania gender, transmitted to the human being through the bite of Phlebotomus spp. Visceral leishmaniasis (VL) is the most severe presentation, even lethal without proper treatment. It has been associated not only with marked immunologic deregulation (allowing the lymphomagenesis), but also with antigenic persistent stimulation which can originate clonal expansion.

pdf (Español (España))

References

1. Guías para el manejo de Leishmanisis Visceral. Ministerio de Salud de la Nación. Año 2010.
2. Wilson ME, Jeronimo SM, Pearson RD. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog. 2005 Apr;38(4):147-60
3. Vase MØ, Hellberg YK, Larsen CS, Petersen E, Schaumburg H, Bendix K, Ravel C, Bastien P, Christensen M, d’Amore F. Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis. Acta Haematol. 2012;128(1):20-2.
4. Domingues M, Menezes Y, Ostronoff F, Calixto R, Florencio R, Sucupira A, Souto-Maior AP, Ostronoff M. Coexistence of Leishmaniasis and Hodgkin’s lymphoma in a lymph node. J Clin Oncol. 2009 Nov 10;27(32):e184-5 5. Daneshbod Y, Dehghani SJ, Nikzad M, Daneshbod K. Visceral leishmaniasis in a case of acute lymphoblastic leukemia at both remission and relapse, diagnosed by bone marrow aspiration. Acta Cytol. 2010 Sep-Oct;54(5):743-6.
6. Osakwe NM, Paulus A, Haggerty PF, Wood RA, Becker SJ, Weina PJ, Dolan MJ, Prakash V. Visceral leishmaniasis with associated immune dysregulation leading to lymphoma. Mil Med. 2013 Mar;178(3):e386-9.
7. Randi ML, Ruzzon E, Tezza F, Tezza F, Pacquola E, Fabris F. Monoclonal gammopathy in human leishmaniasis. Neth J Med. 2006 Feb;64(2):50-1.
8. Komitopoulou A, Tzenou T, Baltadakis J, Apostolidis J, Karakasis D, Harhalakis N. Is leishmaniasis an “unusual suspect” of infection in allogeneic transplantation? Transpl Infect Dis. 2014
Dec;16(6):1012-8.

All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar

Downloads

Download data is not yet available.